A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

Part of paid clinical trials in Norwalk, Connecticut.

Sponsor
Nuvance Health
Study ID
NCT03250078
Status
Recruiting
Apply to this trial

Conditions

  • Pancreatic Neoplasms

Eligibility Criteria

Sex
ALL
Age
50 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • MRI/MRCP — DIAGNOSTIC_TEST
    An MRI/MRCP plus IV gadolinium contrast with high resolution imaging of the pancreas will be performed annually

Study Details

The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for Pancreatic Cancer.

Key Dates

Start date
Nov 30, 2016
Status verified
Apr 2026
Primary completion
Nov 30, 2030
Completion
Nov 30, 2030

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: FAMILIAL PANCREATIC CANCER and/or GENE MUTATION
    An inherited genetic syndrome associated with Pancreatic Cancer and/or with a strong family history of Pancreatic Cancer.

Primary Outcome Measure

Early Stage Pancreatic Cancer or Precursor Lesions [ Time Frame: Through study completion, up to 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Nuvance HealthNorwalkConnecticut06856
Tammy Lo, APRN
[email protected]
203-855-3551
Pramila Krumholtz, RN
[email protected]
203-739-7997
Richard Frank, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Norwalk, CT

By research site
Nuvance Health· Norwalk, CT

Related Studies